Essure Banned and Recalled in Brazil

In February 2017, Brazilian public health agency Agencia Nacional da Vigilancia Sanitaria (“ANVISA”) recalled permanent contraceptive device Essure and banned the sale of the device in Brazil. ANVISA suspended the importation, distribution, use and dissemination of Essure, and recalled units that had already been distributed.

Though Essure bears a “black-box” warning, the strongest issued by the FDA, it continues to be implanted in women today—often leading to side-effects such as pelvic pain, excessive bleeding, device migration, perforation of uterus and related complications. If you or a loved one suffered complications after receiving an Essure implant, please contact us by calling 888-985-7228 for a confidential evaluation of your potential claim.

Real Time Analytics